-
Tirzepatide for Weight LossProduct Name:Tirzepatide for Weight Loss. CAS No.:2023788-19-2. MF:C225H348N48O68. Form: Powder. Specification:10mg/vial 10vials/box. 30mg/vial 10vials/box. 60mg/vial 10vials/box. MOQ: 1 box(10read more
-
Semaglutide Raw PowderProduct name: Semaglutide raw powderCAS No.:910463-68-2Form:Vial PowderFunction:Lose WeightAppearance:White powderSpecification:10mg/vial 10vials/box20mg/vial 10vials/box30mg/vial 10vials/boxMOQ:10read more
-
SLU PP-332 CapsulesProduct Name:SLU-PP-32 capsuleCas number:303760-60-3Appearance:White powderSpecification:250mcg,500mcg,1mg,20mg,100mg/capsule; 60 capsules/bottleForm:CapsulesMOQ:10 bottlesSample:AvailableShippingread more
-
Semaglutide 5mgProduct Name: SemaglutideCAS Number: 910463-68-2Molecular Formula: C187H291N45O59Molar Mass: 4113.58 g/molPurity: ≥98% (HPLC)Specification: 5mg/vial 10vials/boxMOQ: 10 vialsFunction: Lossread more
-
Anti-aging NADProduct Name:Anti-aging NAD. CAS No.:53-84-9. Appearance:White powder. Purity:99%. Form:Vial lyophilized powder. Specification: 500mg/vial 10vials/box 1000mg/vial 10vials/box. Function: Anti-aging.read more
-
Bam-15 CapsulesProduct Name: Bam 15 capsules. CAS No.: 210302-17-3. Appearance: Light yellow powder. Form:Capsules. Specification: 50mg/capsules 60caps/bottle. Function: Lose weight. MOQ:10 bottles.read more
-
Semaglutide for Weight LossProduct name: Semaglutide. CAS No.:910463-68-2. Form: Vial Powder. Function: Lose Weight. Appearance: White powder. Specification:5mg/vial 10vials/box. 10mg/vial 10vials/box. 30mg/vial 10vials/box.read more
-
SLU PP-332 250mcgProduct Name:SLU PP-332 250mcg. Cas number: 303760-60-3. Appearance: White powder. Specification:250mcg/capsule 60 capsules/bottle. Form: Capsules. MOQ: 10 bottles. Sample: Available. Shippingread more
-
Tirzepatide 10mg 30mgProduct Name:Tirzepatide 10mg 30mg. CAS No.:1476486-11-7. Appearance: White loose powder . Purity:99% . Specifications:10mg/vial, 30mg/vial;10vials/box. MOQ:10 boxes . Sample:available. Shelfread more
WebMar 25, 2023 · Mounjaro (Tirzepatide) is the first dual GIP/GLP-1 receptor agonist which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like...
WebJun 25, 2021 · Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is...
WebSep 3, 2020 · Tirzepatide (LY3298176) is a dual GIP and GLP-1 receptor agonist under development for the treatment of type 2 diabetes mellitus (T2DM), obesity, and nonalcoholic steatohepatitis....
WebJun 23, 2023 · Tirzepatide (or matching placebo) was initiated at 2·5 mg once weekly and increased by 2·5 mg every 4 weeks until the target dose was reached (ie, 10 mg or 15 mg at 12 weeks or 20...
WebMay 1, 2023 · Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucagon-like peptide...
Web1 day ago · Tirzepatide, an injectable drug, targets two obesity-related hormones, glucagon-like peptide 1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP; orforglipron targets...
